Literature DB >> 19912202

Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men.

Sang E Lee1, Dae S Kim, Won K Lee, Hong Z Park, Chang J Lee, Seung H Doo, Seong J Jeong, Cheol Y Yoon, Seok-Soo Byun, Gheeyoung Choe, Sung I Hwang, Hak J Lee, Sung K Hong.   

Abstract

OBJECTIVE: To investigate the rate of pathologically confirmed unfavourable prostate cancers among Korean men who fulfilled the contemporary Epstein criteria for clinically insignificant prostate cancer. PATIENTS AND METHODS: This was a retrospective study of 131 Korean men who underwent radical prostatectomy (RP) for clinically insignificant prostate cancer as defined by contemporary Epstein criteria. We assessed the percentage of unfavourable prostate cancer (pathological Gleason sum > or = 7 and/or extraprostatic extension [EPE]) among these men and tried to identify useful predictors for such unfavourable tumour profiles using uni- and multivariate analyses.
RESULTS: Among 131 men with clinically insignificant prostate cancer, 40 (30.5%) had pathological Gleason > or = 7 tumours after RP. Of these 40 men, four (3.1%) also had EPE on examination of RP specimen. All those who did not have Gleason score upgrading after RP had organ-confined disease from examination of RP specimen. Overall, 40 (30.5%) of the 131 men who fulfilled the contemporary Epstein criteria for clinically insignificant prostate cancer before RP had pathologically unfavourable disease. Among our patients, no significant preoperative predictor of pathologically unfavourable disease was identified using uni- and multivariate analyses.
CONCLUSION: Our results showed that a significant proportion of contemporary Korean patients who meet all the conditions of the contemporary Epstein criteria for prediction of clinically insignificant prostate cancer might actually harbour prostate cancer with unfavourable pathological features. Such findings should be considered when treatment options are contemplated based upon the Epstein criteria among Asian patients.

Entities:  

Mesh:

Year:  2009        PMID: 19912202     DOI: 10.1111/j.1464-410X.2009.09070.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  19 in total

Review 1.  Active surveillance for low-risk prostate cancer: an update.

Authors:  Nathan Lawrentschuk; Laurence Klotz
Journal:  Nat Rev Urol       Date:  2011-04-26       Impact factor: 14.432

2.  Validation of revised Epstein's criteria for insignificant prostate cancer prediction in a Greek subpopulation.

Authors:  Κ Chondros; Ν Karpathakis; Ι Heretis; Ε Mavromanolakis; N Chondros; F Sofras; C Mamoulakis
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

Review 3.  Biomarker research in prostate cancer--towards utility, not futility.

Authors:  Sheng Fei Oon; Stephen R Pennington; John M Fitzpatrick; R William G Watson
Journal:  Nat Rev Urol       Date:  2011-03       Impact factor: 14.432

Review 4.  Formalized prediction of clinically significant prostate cancer: is it possible?

Authors:  Carvell T Nguyen; Michael W Kattan
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

5.  Diagnostic Accuracy of Contemporary Selection Criteria in Prostate Cancer Patients Eligible for Active Surveillance: A Bayesian Network Meta-Analysis.

Authors:  Yu Fan; Yelin Mulati; Lingyun Zhai; Yuke Chen; Yu Wang; Juefei Feng; Wei Yu; Qian Zhang
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

6.  Pathologic results of radical prostatectomies in patients with simultaneous atypical small acinar proliferation and prostate cancer.

Authors:  Kwang Ho Kim; Yun Beom Kim; Jeong Kee Lee; Yoon Jung Kim; Tae Young Jung
Journal:  Korean J Urol       Date:  2010-06-21

7.  Active surveillance for favorable-risk prostate cancer: a short review.

Authors:  Nathan Lawrentschuk; Laurence Klotz
Journal:  Korean J Urol       Date:  2010-10-21

8.  Are clinically insignificant prostate cancers really insignificant among Korean men?

Authors:  Chan Dong Yeom; Seung Hwan Lee; Kyung Kgi Park; Sang Un Park; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

9.  Is small prostate volume a predictor of Gleason score upgrading after radical prostatectomy?

Authors:  Mun Su Chung; Seung Hwan Lee; Dong Hoon Lee; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

10.  Prostate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsy.

Authors:  Masahiro Yashi; Tomoya Mizuno; Hideo Yuki; Akinori Masuda; Tsunehito Kambara; Hironori Betsunoh; Hideyuki Abe; Yoshitatsu Fukabori; Osamu Muraishi; Koyu Suzuki; Yoshimasa Nakazato; Takao Kamai
Journal:  BMC Urol       Date:  2014-05-29       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.